Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ailsa Hart

Showing results (91-100 of 177) with videos related to

Pageof 18
Sort By:
Digestive Diseases and Sciences|July 19, 2020
Randomized Trial of Ciprofloxacin Doxycycline and Hydroxychloroquine Versus Budesonide in Active Crohn's DiseaseJonathan M Rhodes, Sreedhar Subramanian, Paul K Flanagan, et al.
Gut|June 22, 2014
A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's diseaseKrisztina B Gecse, Willem Bemelman, Michael A Kamm, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 9, 2019
Multidisciplinary management of the nocebo effect in biosimilar-treated IBD patients: Results of a workshop from the NOCE-BIO consensus groupFerdinando D'Amico, Lieven Pouillon, Marjorie Argollo, et al.
Journal of Clinical Medicine|February 11, 2023
iSTART-II: An Update on the i Support Therapy-Access to Rapid Treatment (iSTART) Approach for Patient-Centered Therapy in Mild-to-Moderate Ulcerative ColitisFerdinando D'Amico, Fernando Magro, Benedicte Caron, et al.
Inflammatory Bowel Diseases|August 7, 2023
Disease Clearance as a New Outcome in Ulcerative Colitis: a Systematic Review and Expert ConsensusFerdinando D'Amico, Fernando Magro, Britta Siegmund, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 18, 2024
Mucosal Healing With Vedolizumab in Patients With Chronic Pouchitis: EARNEST, a Randomized, Double-Blind, Placebo-Controlled TrialVipul Jairath, Brian G Feagan, Mark S Silverberg, et al.
The New England Journal of Medicine|March 29, 2023
Vedolizumab for the Treatment of Chronic PouchitisSimon Travis, Mark S Silverberg, Silvio Danese, et al.
Gut|April 29, 2019
A blood-based prognostic biomarker in IBDDaniele Biasci, James C Lee, Nurulamin M Noor, et al.
Alimentary Pharmacology & Therapeutics|April 9, 2024
Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remissionArta Aliu, Daan H C A Bosch, Daniel Keszthelyi, et al.
Alimentary Pharmacology & Therapeutics|December 2, 2021
Safety and efficacy of tofacitinib for treatment of ulcerative colitis: final analysis of OCTAVE Open, an open-label, long-term extension study with up to 7.0 years of treatmentWilliam J Sandborn, Nervin Lawendy, Silvio Danese, et al.
Pageof 18

Showing results (91-100 of 177) with videos related to

Sort By:
Pageof 18
Digestive Diseases and Sciences|July 19, 2020
Randomized Trial of Ciprofloxacin Doxycycline and Hydroxychloroquine Versus Budesonide in Active Crohn's DiseaseJonathan M Rhodes, Sreedhar Subramanian, Paul K Flanagan, et al.
Gut|June 22, 2014
A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's diseaseKrisztina B Gecse, Willem Bemelman, Michael A Kamm, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 9, 2019
Multidisciplinary management of the nocebo effect in biosimilar-treated IBD patients: Results of a workshop from the NOCE-BIO consensus groupFerdinando D'Amico, Lieven Pouillon, Marjorie Argollo, et al.
Journal of Clinical Medicine|February 11, 2023
iSTART-II: An Update on the i Support Therapy-Access to Rapid Treatment (iSTART) Approach for Patient-Centered Therapy in Mild-to-Moderate Ulcerative ColitisFerdinando D'Amico, Fernando Magro, Benedicte Caron, et al.
Inflammatory Bowel Diseases|August 7, 2023
Disease Clearance as a New Outcome in Ulcerative Colitis: a Systematic Review and Expert ConsensusFerdinando D'Amico, Fernando Magro, Britta Siegmund, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 18, 2024
Mucosal Healing With Vedolizumab in Patients With Chronic Pouchitis: EARNEST, a Randomized, Double-Blind, Placebo-Controlled TrialVipul Jairath, Brian G Feagan, Mark S Silverberg, et al.
The New England Journal of Medicine|March 29, 2023
Vedolizumab for the Treatment of Chronic PouchitisSimon Travis, Mark S Silverberg, Silvio Danese, et al.
Gut|April 29, 2019
A blood-based prognostic biomarker in IBDDaniele Biasci, James C Lee, Nurulamin M Noor, et al.
Alimentary Pharmacology & Therapeutics|April 9, 2024
Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remissionArta Aliu, Daan H C A Bosch, Daniel Keszthelyi, et al.
Alimentary Pharmacology & Therapeutics|December 2, 2021
Safety and efficacy of tofacitinib for treatment of ulcerative colitis: final analysis of OCTAVE Open, an open-label, long-term extension study with up to 7.0 years of treatmentWilliam J Sandborn, Nervin Lawendy, Silvio Danese, et al.
Pageof 18